Aemilia Katzinski is a seasoned professional in the biotechnology and pharmaceuticals industry with extensive experience in cell therapy and laboratory operations. Currently serving as a Manufacturing Associate II at CTMC, a joint venture between Resilience and MD Anderson Cancer Center since October 2022, Aemilia previously held positions as Cell Therapy Specialist II and Cell Therapy Specialist I at Catalent Pharma Solutions from August 2021 to October 2022. Prior experience includes working as a Laboratory Technician at Oxford BioDynamics Plc from March 2020 to August 2021. Aemilia holds a Bachelor of Science degree in Biomedical Sciences from Oxford Brookes University.
This person is not in any offices
CTMC / A joint venture between Resilience + MD Anderson Cancer Center
Cell Therapy Manufacturing Center (CTMC) is a joint venture between Resilience and MD Anderson Cancer Center. CTMC was created to bring together the leading complex biologics manufacturing technology organization and the #1 clinical cancer center to enable innovation from academia and biotech to accelerate Cell Therapy’s impact for cancer patients.
Employees
51-200